SHARE

Apollo invests in Swiss dental medtech vVardis at $1bn-plus valuation

The private equity firm has taken a minority stake in the dental medtech group, valuing it above $1bn and giving it unicorn status. The investment will fund US and Europe expansion of its non-invasive cavity treatment technology.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.